aluates Reports

$ 0.0

Automative

Coronavirus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-14L5853

Global Coronavirus Vaccine Market Size Status and Forecast 2022 2028

BUY CHAPTERS

Coronavirus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-14L5853

Report

October 2024

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Іnоvіо Рhаrmасеutісаlѕ

Моdеrnа

Nоvаvах

Рrоtеіn Роtеntіаl

АlрhаVах

Ѕуnаіrgеn РLС

NаnоVіrісіdеѕ

GGеnеСurе

Coronavirus Vaccine - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Coronavirus Vaccine - Market

Coronavirus vaccines refer to biological products made from coronaviruses for vaccination. It mainly includes inactivated coronavirus vaccine, live attenuated coronavirus vaccine, coronavirus vaccine based on S protein and so on.

The global market for Coronavirus Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coronavirus Vaccine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Coronavirus Vaccine by region & country, by Type, and by Application.

The Coronavirus Vaccine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronavirus Vaccine.

Market Segmentation

Scope of Coronavirus Vaccine - Market Report

Report Metric	Details
Report Name	Coronavirus Vaccine - Market
CAGR	5%
Segment by Type:	Coronavirus Inactivated Vaccine Live Attenuated Coronavirus Vaccine Coronavirus Vaccine Based On S Protein
Segment by Application	Hospital Clinic Research Institute
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Іnоvіо Рhаrmасеutісаlѕ, Моdеrnа, Nоvаvах, Рrоtеіn Роtеntіаl, АlрhаVах, Ѕуnаіrgеn РLС, NаnоVіrісіdеѕ, GGеnеСurе
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Coronavirus Vaccine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Coronavirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Coronavirus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Coronavirus Vaccine - Market report?

Ans: The main players in the Coronavirus Vaccine - Market are Іnоvіо Рhаrmасеutісаlѕ, Моdеrnа, Nоvаvах, Рrоtеіn Роtеntіаl, АlрhаVах, Ѕуnаіrgеn РLС, NаnоVіrісіdеѕ, GGеnеСurе

What are the Application segmentation covered in the Coronavirus Vaccine - Market report?

Ans: The Applications covered in the Coronavirus Vaccine - Market report are Hospital, Clinic, Research Institute

What are the Type segmentation covered in the Coronavirus Vaccine - Market report?

Ans: The Types covered in the Coronavirus Vaccine - Market report are Coronavirus Inactivated Vaccine, Live Attenuated Coronavirus Vaccine, Coronavirus Vaccine Based On S Protein

Recommended Reports

COVID-19 Related Markets

Vaccine Technologies

Pediatric & Specialized Vaccines

1 Market Overview

1.1 Coronavirus Vaccine Product Introduction

1.2 Global Coronavirus Vaccine Market Size Forecast

1.3 Coronavirus Vaccine Market Trends & Drivers

1.3.1 Coronavirus Vaccine Industry Trends

1.3.2 Coronavirus Vaccine Market Drivers & Opportunity

1.3.3 Coronavirus Vaccine Market Challenges

1.3.4 Coronavirus Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Coronavirus Vaccine Players Revenue Ranking (2023)

2.2 Global Coronavirus Vaccine Revenue by Company (2019-2024)

2.3 Key Companies Coronavirus Vaccine Manufacturing Base Distribution and Headquarters

2.4 Key Companies Coronavirus Vaccine Product Offered

2.5 Key Companies Time to Begin Mass Production of Coronavirus Vaccine

2.6 Coronavirus Vaccine Market Competitive Analysis

2.6.1 Coronavirus Vaccine Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Coronavirus Vaccine Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Vaccine as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Coronavirus Inactivated Vaccine

3.1.2 Live Attenuated Coronavirus Vaccine

3.1.3 Coronavirus Vaccine Based On S Protein

3.2 Global Coronavirus Vaccine Sales Value by Type

3.2.1 Global Coronavirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Coronavirus Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Coronavirus Vaccine Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Research Institute

4.2 Global Coronavirus Vaccine Sales Value by Application

4.2.1 Global Coronavirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Coronavirus Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Coronavirus Vaccine Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Coronavirus Vaccine Sales Value by Region

5.1.1 Global Coronavirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Coronavirus Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Coronavirus Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Coronavirus Vaccine Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Coronavirus Vaccine Sales Value, 2019-2030

5.2.2 North America Coronavirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Coronavirus Vaccine Sales Value, 2019-2030

5.3.2 Europe Coronavirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Coronavirus Vaccine Sales Value, 2019-2030

5.4.2 Asia Pacific Coronavirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Coronavirus Vaccine Sales Value, 2019-2030

5.5.2 South America Coronavirus Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Coronavirus Vaccine Sales Value, 2019-2030

5.6.2 Middle East & Africa Coronavirus Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Coronavirus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Coronavirus Vaccine Sales Value

6.3 United States

6.3.1 United States Coronavirus Vaccine Sales Value, 2019-2030

6.3.2 United States Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Coronavirus Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Coronavirus Vaccine Sales Value, 2019-2030

6.4.2 Europe Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Coronavirus Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Coronavirus Vaccine Sales Value, 2019-2030

6.5.2 China Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Coronavirus Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Coronavirus Vaccine Sales Value, 2019-2030

6.6.2 Japan Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Coronavirus Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Coronavirus Vaccine Sales Value, 2019-2030

6.7.2 South Korea Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Coronavirus Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Coronavirus Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Coronavirus Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Coronavirus Vaccine Sales Value, 2019-2030

6.9.2 India Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Coronavirus Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Іnоvіо Рhаrmасеutісаlѕ

7.1.1 Іnоvіо Рhаrmасеutісаlѕ Profile

7.1.2 Іnоvіо Рhаrmасеutісаlѕ Main Business

7.1.3 Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Products, Services and Solutions

7.1.4 Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.1.5 Іnоvіо Рhаrmасеutісаlѕ Recent Developments

7.2 Моdеrnа

7.2.1 Моdеrnа Profile

7.2.2 Моdеrnа Main Business

7.2.3 Моdеrnа Coronavirus Vaccine Products, Services and Solutions

7.2.4 Моdеrnа Coronavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.2.5 Моdеrnа Recent Developments

7.3 Nоvаvах

7.3.1 Nоvаvах Profile

7.3.2 Nоvаvах Main Business

7.3.3 Nоvаvах Coronavirus Vaccine Products, Services and Solutions

7.3.4 Nоvаvах Coronavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.3.5 Рrоtеіn Роtеntіаl Recent Developments

7.4 Рrоtеіn Роtеntіаl

7.4.1 Рrоtеіn Роtеntіаl Profile

7.4.2 Рrоtеіn Роtеntіаl Main Business

7.4.3 Рrоtеіn Роtеntіаl Coronavirus Vaccine Products, Services and Solutions

7.4.4 Рrоtеіn Роtеntіаl Coronavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.4.5 Рrоtеіn Роtеntіаl Recent Developments

7.5 АlрhаVах

7.5.1 АlрhаVах Profile

7.5.2 АlрhаVах Main Business

7.5.3 АlрhаVах Coronavirus Vaccine Products, Services and Solutions

7.5.4 АlрhаVах Coronavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.5.5 АlрhаVах Recent Developments

7.6 Ѕуnаіrgеn РLС

7.6.1 Ѕуnаіrgеn РLС Profile

7.6.2 Ѕуnаіrgеn РLС Main Business

7.6.3 Ѕуnаіrgеn РLС Coronavirus Vaccine Products, Services and Solutions

7.6.4 Ѕуnаіrgеn РLС Coronavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.6.5 Ѕуnаіrgеn РLС Recent Developments

7.7 NаnоVіrісіdеѕ

7.7.1 NаnоVіrісіdеѕ Profile

7.7.2 NаnоVіrісіdеѕ Main Business

7.7.3 NаnоVіrісіdеѕ Coronavirus Vaccine Products, Services and Solutions

7.7.4 NаnоVіrісіdеѕ Coronavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.7.5 NаnоVіrісіdеѕ Recent Developments

7.8 GGеnеСurе

7.8.1 GGеnеСurе Profile

7.8.2 GGеnеСurе Main Business

7.8.3 GGеnеСurе Coronavirus Vaccine Products, Services and Solutions

7.8.4 GGеnеСurе Coronavirus Vaccine Revenue (US$ Million) & (2019-2024)

7.8.5 GGеnеСurе Recent Developments

8 Industry Chain Analysis

8.1 Coronavirus Vaccine Industrial Chain

8.2 Coronavirus Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Coronavirus Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Coronavirus Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Іnоvіо Рhаrmасеutісаlѕ

Моdеrnа

Nоvаvах

Рrоtеіn Роtеntіаl

АlрhаVах

Ѕуnаіrgеn РLС

NаnоVіrісіdеѕ

GGеnеСurе

List of Tables

Table 1. Coronavirus Vaccine Market Trends

Table 2. Coronavirus Vaccine Market Drivers & Opportunity

Table 3. Coronavirus Vaccine Market Challenges

Table 4. Coronavirus Vaccine Market Restraints

Table 5. Global Coronavirus Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Coronavirus Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Coronavirus Vaccine Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Coronavirus Vaccine Product Type

Table 9. Key Companies Time to Begin Mass Production of Coronavirus Vaccine

Table 10. Global Coronavirus Vaccine Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronavirus Vaccine as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Coronavirus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Coronavirus Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Coronavirus Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Coronavirus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Coronavirus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Coronavirus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Coronavirus Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Coronavirus Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Coronavirus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Coronavirus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Coronavirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Coronavirus Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Coronavirus Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Coronavirus Vaccine Sales Value by Region (2019-2024) & (%)

Table 27. Global Coronavirus Vaccine Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Coronavirus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Coronavirus Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Coronavirus Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 31. Іnоvіо Рhаrmасеutісаlѕ Basic Information List

Table 32. Іnоvіо Рhаrmасеutісаlѕ Description and Business Overview

Table 33. Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Products, Services and Solutions

Table 34. Revenue (US$ Million) in Coronavirus Vaccine Business of Іnоvіо Рhаrmасеutісаlѕ (2019-2024)

Table 35. Іnоvіо Рhаrmасеutісаlѕ Recent Developments

Table 36. Моdеrnа Basic Information List

Table 37. Моdеrnа Description and Business Overview

Table 38. Моdеrnа Coronavirus Vaccine Products, Services and Solutions

Table 39. Revenue (US$ Million) in Coronavirus Vaccine Business of Моdеrnа (2019-2024)

Table 40. Моdеrnа Recent Developments

Table 41. Nоvаvах Basic Information List

Table 42. Nоvаvах Description and Business Overview

Table 43. Nоvаvах Coronavirus Vaccine Products, Services and Solutions

Table 44. Revenue (US$ Million) in Coronavirus Vaccine Business of Nоvаvах (2019-2024)

Table 45. Nоvаvах Recent Developments

Table 46. Рrоtеіn Роtеntіаl Basic Information List

Table 47. Рrоtеіn Роtеntіаl Description and Business Overview

Table 48. Рrоtеіn Роtеntіаl Coronavirus Vaccine Products, Services and Solutions

Table 49. Revenue (US$ Million) in Coronavirus Vaccine Business of Рrоtеіn Роtеntіаl (2019-2024)

Table 50. Рrоtеіn Роtеntіаl Recent Developments

Table 51. АlрhаVах Basic Information List

Table 52. АlрhаVах Description and Business Overview

Table 53. АlрhаVах Coronavirus Vaccine Products, Services and Solutions

Table 54. Revenue (US$ Million) in Coronavirus Vaccine Business of АlрhаVах (2019-2024)

Table 55. АlрhаVах Recent Developments

Table 56. Ѕуnаіrgеn РLС Basic Information List

Table 57. Ѕуnаіrgеn РLС Description and Business Overview

Table 58. Ѕуnаіrgеn РLС Coronavirus Vaccine Products, Services and Solutions

Table 59. Revenue (US$ Million) in Coronavirus Vaccine Business of Ѕуnаіrgеn РLС (2019-2024)

Table 60. Ѕуnаіrgеn РLС Recent Developments

Table 61. NаnоVіrісіdеѕ Basic Information List

Table 62. NаnоVіrісіdеѕ Description and Business Overview

Table 63. NаnоVіrісіdеѕ Coronavirus Vaccine Products, Services and Solutions

Table 64. Revenue (US$ Million) in Coronavirus Vaccine Business of NаnоVіrісіdеѕ (2019-2024)

Table 65. NаnоVіrісіdеѕ Recent Developments

Table 66. GGеnеСurе Basic Information List

Table 67. GGеnеСurе Description and Business Overview

Table 68. GGеnеСurе Coronavirus Vaccine Products, Services and Solutions

Table 69. Revenue (US$ Million) in Coronavirus Vaccine Business of GGеnеСurе (2019-2024)

Table 70. GGеnеСurе Recent Developments

Table 71. Key Raw Materials Lists

Table 72. Raw Materials Key Suppliers Lists

Table 73. Coronavirus Vaccine Downstream Customers

Table 74. Coronavirus Vaccine Distributors List

Table 75. Research Programs/Design for This Report

Table 76. Key Data Information from Secondary Sources

Table 77. Key Data Information from Primary Sources

Table 78. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Coronavirus Vaccine Product Picture

Figure 2. Global Coronavirus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Coronavirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Coronavirus Vaccine Report Years Considered

Figure 5. Global Coronavirus Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Coronavirus Vaccine Revenue in 2023

Figure 7. Coronavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Coronavirus Inactivated Vaccine Picture

Figure 9. Live Attenuated Coronavirus Vaccine Picture

Figure 10. Coronavirus Vaccine Based On S Protein Picture

Figure 11. Global Coronavirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Coronavirus Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Hospital

Figure 14. Product Picture of Clinic

Figure 15. Product Picture of Research Institute

Figure 16. Global Coronavirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Coronavirus Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Coronavirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Coronavirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Coronavirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Coronavirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Coronavirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Coronavirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Coronavirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Coronavirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Coronavirus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Coronavirus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Coronavirus Vaccine Sales Value (%), (2019-2030)

Figure 29. United States Coronavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Coronavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Coronavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Coronavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 35. China Coronavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 37. China Coronavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Coronavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Coronavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Coronavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Coronavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Coronavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Coronavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 47. India Coronavirus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Coronavirus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 49. India Coronavirus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 50. Coronavirus Vaccine Industrial Chain

Figure 51. Coronavirus Vaccine Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Coronavirus Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 RNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Novel Coronavirus Vaccine for Inhalation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 Vaccines Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Coronavirus Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Coronavirus Testing Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Coronavirus Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Novel Coronavirus Inactivated Vaccine Market Research Report 2025

Global Coronavirus Test Kit Market Research Report 2024

Global Coronavirus Assay Kit Market Research Report 2025

COVID 19 DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Commercial Fish Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rabies Vaccines for Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Animal Flu Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Virus Vaccines Market Research Report 2024

Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Virus Vaccine H1N1 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions